LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.

    Chen, Duojiao / Parker, Taylor M / Bhat-Nakshatri, Poornima / Chu, Xiaona / Liu, Yunlong / Wang, Yue / Nakshatri, Harikrishna

    Oncogene

    2021  Volume 40, Issue 7, Page(s) 1332–1346

    Abstract: Chromatin accessibility is central to basal and inducible gene expression. Through ATAC-seq experiments in estrogen receptor-positive (ER+) breast cancer cell line MCF-7 and integration with multi-omics data, we found estradiol (E2) induced chromatin ... ...

    Abstract Chromatin accessibility is central to basal and inducible gene expression. Through ATAC-seq experiments in estrogen receptor-positive (ER+) breast cancer cell line MCF-7 and integration with multi-omics data, we found estradiol (E2) induced chromatin accessibility changes in a small number of breast cancer-relevant E2-regulated genes. As expected, open chromatin regions associated with E2-inducible gene expression showed enrichment of estrogen response element (ERE) and those associated with E2-repressible gene expression were enriched for ERE, PBX1, and PBX3. While a significant number of open chromatin regions showed pioneer factor FOXA1 occupancy in the absence of E2, E2-treatment further enhanced FOXA1 occupancy suggesting that ER-E2 enhances chromatin occupancy of FOXA1 to a subset of E2-regulated genes. Surprisingly, promoters of 80% and enhancers of 60% of E2-inducible genes displayed closed chromatin configuration both in the absence and presence of E2. Integration of ATAC-seq data with ERα ChIP-seq data revealed that ~40% ERα binding sites in the genome are found in chromatin regions that are not accessible as per ATAC-seq. Such ERα binding regions were enriched for binding sites of multiple nuclear receptors including ER, ESRRB, ERRγ, COUP-TFII (NR2F2), RARα, EAR2 as well as traditional pioneer factors FOXA1 and GATA3. Similar data were also obtained when ERα ChIP-seq data were integrated with MNase-seq and DNase-seq data sets. In summation, our results reveal complex mechanisms of ER-E2 interaction with nucleosomes. Notably, "closed chromatin" configuration as defined by ATAC-seq or by other techniques is not necessarily associated with lack of gene expression and technical limitations may preclude ATAC-seq to demonstrate accessibility of chromatin regions that are bound by ERα.
    MeSH term(s) Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; COUP Transcription Factor II/genetics ; Cell Line, Tumor ; Chromatin/genetics ; Estradiol/genetics ; Estradiol/metabolism ; Estrogen Receptor alpha/genetics ; Female ; GATA3 Transcription Factor/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Hepatocyte Nuclear Factor 3-alpha/genetics ; Humans ; MCF-7 Cells ; Promoter Regions, Genetic/genetics ; Receptors, Estrogen/genetics ; Retinoic Acid Receptor alpha/genetics
    Chemical Substances COUP Transcription Factor II ; Chromatin ; ESRRB protein, human ; Estrogen Receptor alpha ; FOXA1 protein, human ; GATA3 Transcription Factor ; GATA3 protein, human ; Hepatocyte Nuclear Factor 3-alpha ; NR2F2 protein, human ; Receptors, Estrogen ; Retinoic Acid Receptor alpha ; Estradiol (4TI98Z838E)
    Language English
    Publishing date 2021-01-08
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639046-8
    ISSN 1476-5594 ; 0950-9232
    ISSN (online) 1476-5594
    ISSN 0950-9232
    DOI 10.1038/s41388-020-01607-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cell competition and tumor heterogeneity.

    Parker, Taylor M / Henriques, Vanessa / Beltran, Antonio / Nakshatri, Harikrishna / Gogna, Rajan

    Seminars in cancer biology

    2019  Volume 63, Page(s) 1–10

    Abstract: Cancers exhibit a remarkable degree of intratumoral heterogeneity (ITH), which results from complex cellular interactions amongst various cell types. This phenomenon provides an opportunity for clonal selection and growth advantages to aggressive cancer ... ...

    Abstract Cancers exhibit a remarkable degree of intratumoral heterogeneity (ITH), which results from complex cellular interactions amongst various cell types. This phenomenon provides an opportunity for clonal selection and growth advantages to aggressive cancer cell types, resulting in worse prognosis and challenges to anti-cancer therapy. Cell competition is a conserved mechanism operational in cellular and organ systems, which allows neighboring cells to compare their relative fitness levels and results in the elimination of viable but suboptimal cells. By abuse of this conserved homeostasis mechanism, aggressive cancer cell types gain an advantage over normal cell types by achieving traits like increased proliferation, de-differentiation, and stemness. This review presents recent evidence that cell competition mechanisms actively participate in the regulation of intratumoral cell-cell interactions and thus contribute to ITH, and this process is essential for cancer development and progression.
    MeSH term(s) Animals ; Cell Communication/physiology ; Cell Differentiation/physiology ; Disease Progression ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasms/etiology ; Neoplasms/genetics ; Neoplasms/metabolism ; Neoplasms/pathology ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology
    Language English
    Publishing date 2019-09-09
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1033980-2
    ISSN 1096-3650 ; 1044-579X
    ISSN (online) 1096-3650
    ISSN 1044-579X
    DOI 10.1016/j.semcancer.2019.09.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.

    Marsh, Amanda M / Nguyen, Austin Huy / Parker, Taylor M / Agrawal, Devendra K

    Canadian journal of physiology and pharmacology

    2017  Volume 95, Issue 3, Page(s) 253–259

    Abstract: Heart failure (HF) is a clinical syndrome that represents the end stage of heart disease and remains the leading cause of morbidity and mortality worldwide. As heart failure mortality rates remain elevated, additional biomarkers that facilitate early ... ...

    Abstract Heart failure (HF) is a clinical syndrome that represents the end stage of heart disease and remains the leading cause of morbidity and mortality worldwide. As heart failure mortality rates remain elevated, additional biomarkers that facilitate early detection or risk stratification in HF is of particularly great interest. High mobility group box 1 (HMGB1) and receptor for advanced glycation end products (RAGE) cause the activation of intracellular signaling, gene expression, and production of inflammatory cytokines and have been linked to many inflammatory disease states such as diabetes mellitus and atherosclerosis. Few studies have investigated their role in the pathophysiology of HF and any significant correlation remains uncertain. Review of the available literature discussing HMGB1 and RAGE clinical values as independent prognostic variables in HF resulted in the inclusion of 11 studies, which enrolled a total of 2025 heart failure patients. Overall, the data suggests a statistically significant positive correlation between RAGE and HF, with increasing RAGE levels associated with increasing New York Heart Association (NYHA) functional class of heart failure. HMGB1 correlations were not as extensively studied, but there is evidence that both HMGB1 and RAGE have a definite potential as biomarkers for the prognosis and risk stratification of HF patients.
    MeSH term(s) Biomarkers/metabolism ; HMGB1 Protein/metabolism ; Heart Failure/diagnosis ; Heart Failure/metabolism ; Heart Failure/physiopathology ; Heart Failure/therapy ; Humans ; Predictive Value of Tests ; Prognosis ; Receptor for Advanced Glycation End Products/metabolism ; Reproducibility of Results ; Risk Factors ; Severity of Illness Index ; Up-Regulation
    Chemical Substances AGER protein, human ; Biomarkers ; HMGB1 Protein ; HMGB1 protein, human ; Receptor for Advanced Glycation End Products
    Language English
    Publishing date 2017-03
    Publishing country Canada
    Document type Journal Article ; Review
    ZDB-ID 127527-6
    ISSN 1205-7541 ; 0008-4212
    ISSN (online) 1205-7541
    ISSN 0008-4212
    DOI 10.1139/cjpp-2016-0299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cell competition in intratumoral and tumor microenvironment interactions.

    Parker, Taylor M / Gupta, Kartik / Palma, António M / Yekelchyk, Michail / Fisher, Paul B / Grossman, Steven R / Won, Kyoung Jae / Madan, Esha / Moreno, Eduardo / Gogna, Rajan

    The EMBO journal

    2021  Volume 40, Issue 17, Page(s) e107271

    Abstract: Tumors are complex cellular and acellular environments within which cancer clones are under continuous selection pressures. Cancer cells are in a permanent mode of interaction and competition with each other as well as with the immediate microenvironment. ...

    Abstract Tumors are complex cellular and acellular environments within which cancer clones are under continuous selection pressures. Cancer cells are in a permanent mode of interaction and competition with each other as well as with the immediate microenvironment. In the course of these competitive interactions, cells share information regarding their general state of fitness, with less-fit cells being typically eliminated via apoptosis at the hands of those cells with greater cellular fitness. Competitive interactions involving exchange of cell fitness information have implications for tumor growth, metastasis, and therapy outcomes. Recent research has highlighted sophisticated pathways such as Flower, Hippo, Myc, and p53 signaling, which are employed by cancer cells and the surrounding microenvironment cells to achieve their evolutionary goals by means of cell competition mechanisms. In this review, we discuss these recent findings and explain their importance and role in evolution, growth, and treatment of cancer. We further consider potential physiological conditions, such as hypoxia and chemotherapy, that can function as selective pressures under which cell competition mechanisms may evolve differently or synergistically to confer oncogenic advantages to cancer.
    MeSH term(s) Animals ; Cell Competition ; Humans ; Neoplasms/metabolism ; Neoplasms/pathology ; Signal Transduction ; Tumor Microenvironment
    Language English
    Publishing date 2021-08-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 586044-1
    ISSN 1460-2075 ; 0261-4189
    ISSN (online) 1460-2075
    ISSN 0261-4189
    DOI 10.15252/embj.2020107271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The danger zone: Systematic review of the role of HMGB1 danger signalling in traumatic brain injury.

    Parker, Taylor M / Nguyen, Austin Huy / Rabang, Joshua R / Patil, Arun-Angelo / Agrawal, Devendra K

    Brain injury

    2017  Volume 31, Issue 1, Page(s) 2–8

    Abstract: Background: Traumatic brain injuries (TBI) are associated with complex inflammatory pathways that lead to the development of secondary injuries such as cerebral ischaemia, elevated intracranial pressure and cognitive deficits. The association between ... ...

    Abstract Background: Traumatic brain injuries (TBI) are associated with complex inflammatory pathways that lead to the development of secondary injuries such as cerebral ischaemia, elevated intracranial pressure and cognitive deficits. The association between intracellular danger signalling involving nuclear chromatin-binding factor, high mobility group box-1 (HMGB1) and inflammatory pathways following TBI has not yet been fully understood.
    Primary objective: To comprehensively review the available literature regarding the potential diagnostic, prognostic and therapeutic use of HMGB1 in TBI.
    Methods: A systematic literature review of studies available in PubMed using human and animal subjects was performed. A total of eight studies were included in the results.
    Conclusions: A comprehensive review of these reports demonstrated that, following TBI, HMGB1 is released from damaged neurons and is elevated in patient's serum and CSF. Furthermore, these studies showed the potential for HMGB1 to serve as a prognostic biomarker and therapeutic target in patients with TBI. Thus, HMGB1 is a prospective candidate for future studies as it shows promise in treating and/or predicting the sequelae of TBI.
    Language English
    Publishing date 2017
    Publishing country England
    Document type Journal Article
    ZDB-ID 639115-1
    ISSN 1362-301X ; 0269-9052
    ISSN (online) 1362-301X
    ISSN 0269-9052
    DOI 10.1080/02699052.2016.1217045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection.

    Ledet, Grace A / Biswas, Shukla / Kumar, Vidya P / Graves, Richard A / Mitchner, Demaurian M / Parker, Taylor M / Bostanian, Levon A / Ghosh, Sanchita P / Mandal, Tarun K

    International journal of molecular sciences

    2016  Volume 18, Issue 1

    Abstract: The purpose of this study was two-fold: (1) to formulate γ-tocotrienol (GT3) in a nanoemulsion formulation as a prophylactic orally administered radioprotective agent; and (2) to optimize the storage conditions to preserve the structural integrity of ... ...

    Abstract The purpose of this study was two-fold: (1) to formulate γ-tocotrienol (GT3) in a nanoemulsion formulation as a prophylactic orally administered radioprotective agent; and (2) to optimize the storage conditions to preserve the structural integrity of both the formulation and the compound. γ-tocotrienol was incorporated into a nanoemulsion and lyophilized with lactose. Ultra performance liquid chromatography-mass spectroscopy (UPLC-MS) was used to monitor the chemical stability of GT3 over time, the particle size and ζ potential, and scanning electron microscopy (SEM) were used to study the physical stability of the nanoemulsion. Radioprotective and toxicity studies were performed in mice. The liquid formulation exhibited GT3 degradation at all storage temperatures. Lyophilization, in the presence of lactose, significantly reduced GT3 degradation. Both the liquid and lyophilized nanoemulsions had stable particle size and ζ potential when stored at 4 °C. Toxicity studies of the nanoemulsion resulted in no observable toxicity in mice at an oral dose of 600 mg/kg GT3. The nano-formulated GT3 (300 mg/kg) demonstrated enhanced survival efficacy compared to GT3 alone (200 and 400 mg/kg) in CD2F1 mice exposed to total body gamma radiation. The optimal long-term storage of formulated GT3 is as a powder at -20 °C to preserve drug and formulation integrity. Formulation of GT3 as a nanoemulsion for oral delivery as a prophylactic radioprotectant shows promise and warrants further investigation.
    MeSH term(s) Acute Radiation Syndrome/drug therapy ; Acute Radiation Syndrome/prevention & control ; Administration, Oral ; Animals ; Chromans/administration & dosage ; Chromans/adverse effects ; Chromans/chemistry ; Chromans/therapeutic use ; Drug Stability ; Emulsions/chemistry ; Lactose/chemistry ; Male ; Mice ; Radiation-Protective Agents/administration & dosage ; Radiation-Protective Agents/adverse effects ; Radiation-Protective Agents/chemistry ; Radiation-Protective Agents/therapeutic use ; Vitamin E/administration & dosage ; Vitamin E/adverse effects ; Vitamin E/analogs & derivatives ; Vitamin E/chemistry ; Vitamin E/therapeutic use
    Chemical Substances Chromans ; Emulsions ; Radiation-Protective Agents ; Vitamin E (1406-18-4) ; plastochromanol 8 (4382-43-8) ; Lactose (J2B2A4N98G)
    Language English
    Publishing date 2016-12-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms18010028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: HIF-transcribed p53 chaperones HIF-1α.

    Madan, Esha / Parker, Taylor M / Pelham, Christopher J / Palma, Antonio M / Peixoto, Maria L / Nagane, Masaki / Chandaria, Aliya / Tomás, Ana R / Canas-Marques, Rita / Henriques, Vanessa / Galzerano, Antonio / Cabral-Teixeira, Joaquim / Selvendiran, Karuppaiyah / Kuppusamy, Periannan / Carvalho, Carlos / Beltran, Antonio / Moreno, Eduardo / Pati, Uttam K / Gogna, Rajan

    Nucleic acids research

    2019  Volume 47, Issue 19, Page(s) 10212–10234

    Abstract: Chronic hypoxia is associated with a variety of physiological conditions such as rheumatoid arthritis, ischemia/reperfusion injury, stroke, diabetic vasculopathy, epilepsy and cancer. At the molecular level, hypoxia manifests its effects via activation ... ...

    Abstract Chronic hypoxia is associated with a variety of physiological conditions such as rheumatoid arthritis, ischemia/reperfusion injury, stroke, diabetic vasculopathy, epilepsy and cancer. At the molecular level, hypoxia manifests its effects via activation of HIF-dependent transcription. On the other hand, an important transcription factor p53, which controls a myriad of biological functions, is rendered transcriptionally inactive under hypoxic conditions. p53 and HIF-1α are known to share a mysterious relationship and play an ambiguous role in the regulation of hypoxia-induced cellular changes. Here we demonstrate a novel pathway where HIF-1α transcriptionally upregulates both WT and MT p53 by binding to five response elements in p53 promoter. In hypoxic cells, this HIF-1α-induced p53 is transcriptionally inefficient but is abundantly available for protein-protein interactions. Further, both WT and MT p53 proteins bind and chaperone HIF-1α to stabilize its binding at its downstream DNA response elements. This p53-induced chaperoning of HIF-1α increases synthesis of HIF-regulated genes and thus the efficiency of hypoxia-induced molecular changes. This basic biology finding has important implications not only in the design of anti-cancer strategies but also for other physiological conditions where hypoxia results in disease manifestation.
    MeSH term(s) Cell Hypoxia/genetics ; Gene Expression Regulation ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Molecular Chaperones/genetics ; Promoter Regions, Genetic/genetics ; Protein Interaction Maps/genetics ; Response Elements/genetics ; Signal Transduction/genetics ; Tumor Suppressor Protein p53/genetics
    Chemical Substances HIF1A protein, human ; Hypoxia-Inducible Factor 1, alpha Subunit ; Molecular Chaperones ; TP53 protein, human ; Tumor Suppressor Protein p53
    Language English
    Publishing date 2019-09-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkz766
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.

    Madan, Esha / Parker, Taylor M / Bauer, Matthias R / Dhiman, Alisha / Pelham, Christopher J / Nagane, Masaki / Kuppusamy, M Lakshmi / Holmes, Matti / Holmes, Thomas R / Shaik, Kranti / Shee, Kevin / Kiparoidze, Salome / Smith, Sean D / Park, Yu-Soon A / Gomm, Jennifer J / Jones, Louise J / Tomás, Ana R / Cunha, Ana C / Selvendiran, Karuppaiyah /
    Hansen, Laura A / Fersht, Alan R / Hideg, Kálmán / Gogna, Rajan / Kuppusamy, Periannan

    The Journal of biological chemistry

    2018  Volume 293, Issue 12, Page(s) 4262–4276

    Abstract: p53 is an important tumor-suppressor protein that is mutated in more than 50% of cancers. Strategies for restoring normal p53 function are complicated by the oncogenic properties of mutant p53 and have not met with clinical success. To counteract mutant ... ...

    Abstract p53 is an important tumor-suppressor protein that is mutated in more than 50% of cancers. Strategies for restoring normal p53 function are complicated by the oncogenic properties of mutant p53 and have not met with clinical success. To counteract mutant p53 activity, a variety of drugs with the potential to reconvert mutant p53 to an active wildtype form have been developed. However, these drugs are associated with various negative effects such as cellular toxicity, nonspecific binding to other proteins, and inability to induce a wildtype p53 response in cancer tissue. Here, we report on the effects of a curcumin analog, HO-3867, on p53 activity in cancer cells from different origins. We found that HO-3867 covalently binds to mutant p53, initiates a wildtype p53-like anticancer genetic response, is exclusively cytotoxic toward cancer cells, and exhibits high anticancer efficacy in tumor models. In conclusion, HO-3867 is a p53 mutant-reactivating drug with high clinical anticancer potential.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Cell Proliferation/drug effects ; Curcumin/analogs & derivatives ; Curcumin/pharmacology ; Female ; Humans ; Mice ; Mice, Nude ; Mutant Proteins/genetics ; Mutant Proteins/metabolism ; Mutation ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/pathology ; Piperidones/pharmacology ; Tumor Cells, Cultured ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Xenograft Model Antitumor Assays
    Chemical Substances (3,5-bis((4-fluorophenyl)methylidene)-1-((1-hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl)piperidin-4-one) ; Antineoplastic Agents ; Mutant Proteins ; Piperidones ; TP53 protein, human ; Tumor Suppressor Protein p53 ; Curcumin (IT942ZTH98)
    Language English
    Publishing date 2018-01-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.RA117.000950
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Flower isoforms promote competitive growth in cancer.

    Madan, Esha / Pelham, Christopher J / Nagane, Masaki / Parker, Taylor M / Canas-Marques, Rita / Fazio, Kimberly / Shaik, Kranti / Yuan, Youzhong / Henriques, Vanessa / Galzerano, Antonio / Yamashita, Tadashi / Pinto, Miguel Alexandre Ferreira / Palma, Antonio M / Camacho, Denise / Vieira, Ana / Soldini, David / Nakshatri, Harikrishna / Post, Steven R / Rhiner, Christa /
    Yamashita, Hiroko / Accardi, Davide / Hansen, Laura A / Carvalho, Carlos / Beltran, Antonio L / Kuppusamy, Periannan / Gogna, Rajan / Moreno, Eduardo

    Nature

    2019  Volume 572, Issue 7768, Page(s) 260–264

    Abstract: In humans, the adaptive immune system uses the exchange of information between cells to detect and eliminate foreign or damaged cells; however, the removal of unwanted cells does not always require an adaptive immune ... ...

    Abstract In humans, the adaptive immune system uses the exchange of information between cells to detect and eliminate foreign or damaged cells; however, the removal of unwanted cells does not always require an adaptive immune system
    MeSH term(s) Animals ; Calcium Channels/genetics ; Calcium Channels/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Cell Transformation, Neoplastic/genetics ; Drosophila Proteins/metabolism ; Drosophila melanogaster ; Female ; Gene Knockdown Techniques ; Humans ; Male ; Neoplasm Metastasis ; Neoplasms/drug therapy ; Neoplasms/pathology ; Protein Isoforms/genetics ; Protein Isoforms/metabolism
    Chemical Substances CACFD1 protein, human ; Calcium Channels ; Drosophila Proteins ; Protein Isoforms ; fwe protein, Drosophila
    Language English
    Publishing date 2019-07-24
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-019-1429-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top